Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance

• US 9,308,259 B2
• Filed: 05/31/2007
• Issued: 04/12/2016
• Est. Priority Date: 06/06/2006
• Status: Expired due to Fees

• Current Assignee: Oleg Iliich Epshtein
• Original Assignee: Oleg Iliich Epshtein
• Inventors: Epshtein, Oleg Iliich, Sergeeva, Svetlana Alexandrovna
• Primary Examiner(s): OUSPENSKI, ILIA I
• Application Number:
  US12/303,648
• Publication Number:
  US 20110008452A1
• Time in Patent Office: 3,239 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61K 2039/505 comprising antibodies
• CPC Class Codes: A61K 41/0004 Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
• CPC Class Codes: A61P 3/04 Anorexiants; Antiobesity agents
• CPC Class Codes: A61P 3/08 for glucose homeostasis pancreatic hormones A61P5/48
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics
• CPC Class Codes: A61P 5/50 for increasing or potentiating the activity of insulin
• CPC Class Codes: C07K 16/2869 against hormone receptors for antibodies against neuromediator receptors C07K16/286

Abstract

The inventive medicinal agent comprises antibodies against beta-subunit of insulin receptor in an activated form produced by means of repeated serial dilution and an external action performed according to homeopathic technology. The inventive method for producing a solid medicinal formulation for perorally treating fatness, diabetes, and other diseases associated with impaired glucose tolerance, consists in mixing the effective amount of carrier, which is showered in a fluidized layer by a water-alcohol dilution of antibodies in the form active against the beta-subunit of the insulin receptor produced by combining the repeated serial dilution, thereby reducing the concentration of antibodies, and an external action according to homeopathic technology, and is dried at a temperature equal to or less than 35° C., with pharmaceutically acceptable additives and in subsequently pelleting the mixture thus obtained by means of direct dry compression.

Claims

1. A medication for peroral treatment of diabetes mellitus, impaired glucose tolerance and obesity associated with diabetes mellitus or impaired glucose tolerance, comprising a homeopathically potentized form of at least one antibody to the beta-subunit of the insulin receptor.

2. The medication according to claim 1 wherein said at least one antibody is a monoclonal, polyclonal, recombinant, immune or natural antibody.

3. The medication according to claim 1 wherein said homeopathically potentised form of antibody comprises mixture of various homeopathic dilutions.

4. A method for producing a solid oral dosage form of claim 1, the method comprising:

providing a carrier;

irrigating said carrier with a homeopathically potentized form of at least one antibody to the beta-subunit of the insulin receptor;

mixing said carrier with pharmaceutically acceptable additives;

drying said carrier at a temperature not exceeding 35°

C.; and

forming said irrigated carrier into said oral dosage form by direct dry pressing.

5. The method according to claim 4 wherein the carrier is lactose with a particle size of from about 150 μ

m to about 250 μ

m.